BrainStorm Validates Cryopreservation Process of NurOwn for ALS Phase 3 Clinical Trial

BrainStorm Cell Therapeutics has validated the cryopreservation process for its NurOwn stem cells to be used in an upcoming Phase 3 clinical trial in amyotrophic lateral sclerosis (ALS). In the validation study researchers compared NurOwn (MSC-NTF cells) derived from fresh mesenchymal stem cells (MSC) to those derived from…

Feeding mouse models of amyotrophic lateral sclerosis (ALS) the bacterial product butyrate improved their gut health, delayed the onset of movement symptoms, and increased the animals’ life span, according to a study. The study reporting the findings, “Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral…

Patients with amyotrophic lateral sclerosis (ALS) have intact eye muscle movement, even at more advanced stages of the disease, according to new research. However, the reason remains unknown. Researchers say that discovering how this happens may help in the design of novel treatments to fight the loss of muscle activity in…

Many amyotrophic lateral sclerosis (ALS) patients have a vitamin D deficiency, and recent studies have shown that this vitamin can benefit ALS patients. Vitamin D is often called the “sunshine vitamin,” mostly because we can get it naturally when the sun’s UV rays interact with our skin, which triggers the vitamin’s synthesis. This very important vitamin…

The amyotrophic lateral sclerosis (ALS) drug Rilutek (riluzole) prevents neuronal cell death in part by acting on mitochondria, suggesting that treatment approaches that target the way mitochondria signal within cells may be a viable approach to treating ALS. The study, “Riluzole But Not Melatonin Ameliorates Acute Motor…

Flex Pharma said it plans to prioritize developing its clinical programs in neurological diseases, including amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and peripheral neuropathies like Charcot-Marie Tooth (CMT). One or two proof-of-concept, Phase 2 clinical trials are planned for this year in the United States to evaluate the company’s transient receptor…

This Facebook video from Science Nature Page shares a little bit of information about the wearable robot hand that has been designed to help people who have lost function of their hands. Read about six ALS therapies designed to improve quality of life.  The device could help people who…

The advancements in both technology and medicine means that managing symptoms of ALS is now easier than ever before. Doctors are able to make patients much more comfortable and improve their quality of life. There are various areas of medical management needed for people with amyotrophic lateral sclerosis (ALS) and we’ve listed…

Preventing the TDP-43 protein from entering mitochondria may be a treatment option for amyotrophic lateral sclerosis (ALS), according to a new report. But while blocking the abnormal process is possible in mice, the compound used is not suitable for humans. To overcome this, researchers are using multiple approaches in their…

Surgery to insert a feeding tube directly into the stomach of late-stage amyotrophic lateral sclerosis (ALS) patients can be made safer by adapting procedures now in place for high-risk patients, identified with the help of a tool for stratifying patients according to risk. The study, ”A risk stratifying tool to…